AstraZeneca PLC ADRhedged
We have no price for AstraZeneca PLC ADRhedged since 30 January 2026. It may have been taken over, merged or renamed, so the figures below are from then.
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here.
AstraZeneca PLC ADRhedged vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| AstraZeneca PLC ADRhedged | No profit yet | ||
 Atai Beckley N.V | No profit yet | ||
 Avalyn Pharma | No profit yet | ||
 Cullinan Therapeutics | No profit yet | ||
 High Tide | No profit yet |
AI analysis
An AI analyst reads AstraZeneca PLC ADRhedged's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · Nov 1, 2026AstraZeneca Q3 profit beats estimates as cancer drug sales drive growthSeeking Alpha · Oct 30, 2026AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026 outlookSeeking Alpha · Oct 30, 2026AstraZeneca is said to be considering cancer vaccine developmentSeeking Alpha · Oct 27, 2026Summit Therapeutics rises after AstraZeneca commits $2B investmentSeeking Alpha · Sep 28, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about AstraZeneca PLC ADRhedged
Is AstraZeneca PLC ADRhedged a good stock to buy?
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the AstraZeneca PLC ADRhedged AI analysis
What does AstraZeneca PLC ADRhedged do?
The Series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of AstraZeneca PLC (the “Company”). The Series will not invest directly in the Company. It is in Medical - Pharmaceuticals.
Who are AstraZeneca PLC ADRhedged's competitors?
The largest listed companies in the same industry are Atai Beckley N.V, Avalyn Pharma, Cullinan Therapeutics and High Tide. The peers table on this page compares their profit, growth and price with AstraZeneca PLC ADRhedged's.
Prices: daily closes to Jan 30, 2026. Fundamentals: company reports via invest-like data.